03/14/2019
5:57 PM | ARCH Venture Fund VII, L.P. (Reporting)
ARCH Venture Partners VII, L.P. (Reporting)
ARCH Venture Partners VII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
NELSEN ROBERT (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities |  |
03/11/2019
4:58 PM | ARCH Venture Fund VII, L.P. (Reporting)
ARCH Venture Partners VII, L.P. (Reporting)
ARCH Venture Partners VII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
NELSEN ROBERT (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2019
8:18 AM | Syros Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/07/2019
5:32 AM | Syros Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2019
2:07 PM | ARCH Venture Fund VII, L.P. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/14/2019
10:32 AM | ARK Investment Management LLC (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G
| |
02/14/2019
5:28 AM | Polaris Partners VII, L.P. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13D/A
| |
01/11/2019
4:02 PM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2019
5:30 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2018
7:07 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2018
10:50 AM | Syros Pharmaceuticals (Filer)
| Form CT ORDER
| |
11/15/2018
3:03 PM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2018
5:25 AM | Syros Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/26/2018
7:31 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2018
4:01 PM | Syros Pharmaceuticals (Filer)
| Form 10-Q/A
| |
08/24/2018
4:01 PM | Syros Pharmaceuticals (Filer)
| Form 10-Q/A
| |
08/24/2018
4:00 PM | Syros Pharmaceuticals (Filer)
| Form 10-K/A
| |
08/07/2018
5:57 AM | Syros Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/15/2018
3:30 PM | Syros Pharmaceuticals (Issuer)
Young Richard A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
3:30 PM | Syros Pharmaceuticals (Issuer)
WIRTH PETER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
3:29 PM | SHARP PHILIP A (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
3:29 PM | SATO VICKI L (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
3:29 PM | Nashat Amir (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
3:28 PM | Fanucci Marsha (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
3:28 PM | BONNEY MICHAEL W (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
3:24 PM | AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
7:51 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2018
5:49 AM | Syros Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2018
6:04 AM | Syros Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/26/2018
6:03 AM | Syros Pharmaceuticals (Filer)
| Form DEF 14A
| |
03/15/2018
6:55 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2018
4:10 PM | Ferra Joseph J Jr (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2018
4:09 PM | Ferra Joseph J Jr (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/12/2018
6:44 AM | Syros Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/12/2018
6:30 AM | Syros Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/12/2018
6:05 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2018
3:09 PM | Quirk Gerald E (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2018
3:08 PM | Roth David (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2018
3:08 PM | Olson Eric R (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2018
3:08 PM | Simonian Nancy A (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2018
7:52 AM | Flynn James E (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/13/2018
5:43 PM | AFEYAN NOUBAR (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/12/2018
11:15 PM | Syros Pharmaceuticals (Filer)
| Form EFFECT
| |
02/09/2018
7:52 AM | Syros Pharmaceuticals (Filer)
| Form D/A
| |
02/02/2018
3:29 PM | Arch Venture Fund VII LP (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/02/2018
3:14 PM | Syros Pharmaceuticals (Filer)
| Form S-3/A
| |
02/02/2018
3:05 PM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2018
2:53 PM | AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2018
8:24 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2018
3:32 PM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2018
3:30 PM | Syros Pharmaceuticals (Filer)
| Form 424B5
| |
01/19/2018
4:14 PM | Syros Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/17/2018
3:13 PM | Syros Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/12/2018
4:15 PM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2018
7:15 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2017
6:30 PM | AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 3/A
| |
12/15/2017
3:02 PM | Springhorn Jeremy P. (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2017
7:22 PM | AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2017
5:04 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
